Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. De plus, nous expédions Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Protéines (4) et Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Kits (1) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 77 products:
our study demonstrates that the novel pathway lncRNA Ftx/miR (Montrer MLXIP Anticorps)-545/RIG-I (Montrer DDX58 Anticorps) promotes hepatocellular carcinoma development
this review describes antiviral activities of RIG-I (Montrer DDX58 Anticorps) against influenza viruses (standing on three legs)
Study uncovered a novel aspect of Rig-I (Montrer DDX58 Anticorps) in monitoring gut (Montrer GUSB Anticorps) microbiota through regulating IgA and IL6 (Montrer IL6 Anticorps)-STAT3 (Montrer STAT3 Anticorps)-dependent Reg3gamma pathway. Besides, Rig-I (Montrer DDX58 Anticorps) loss could also promote colorectal cancer progression both in the presence and absence of intestinal bacteria.
this study indicated that increased expression of TIG3 in primary glioblastoma is a novel biomarker for predicting poor outcome of patients. We then hypothesize that TIG3 may function in a different pattern in glioblastoma
Foot-and-mouth disease virus Viroporin 2B antagonizes RIG-I (Montrer DDX58 Anticorps)-mediated antiviral effects by inhibition of its protein expression.
Overexpression of TIG3 suppresses tumor growth in hepatocellular carcinoma
miR (Montrer MLXIP Anticorps)-34a is an antioncogene in multiple tumors, in this study, RIG-I (Montrer DDX58 Anticorps) and miR (Montrer MLXIP Anticorps)-34a suppressed cell growth, proliferation, migration, and invasion in cervical cancer cells in vitro. miR (Montrer MLXIP Anticorps)-34a was validated as a new regulator of RIG-I (Montrer DDX58 Anticorps) by binding to its 3' untranslated region and upregulating its expression level.
Letter: Interleukin-22 (Montrer IL22 Anticorps) inhibits tazarotene-induced gene 3 expression in keratinocytes via MAPK (Montrer MAPK1 Anticorps)-ERK1/2 (Montrer MAPK1/3 Anticorps) and JAK2 (Montrer JAK2 Anticorps)/STAT3 (Montrer STAT3 Anticorps) signaling.
TRIM25 (Montrer TRIM25 Anticorps) plays an additional role in RIG-I (Montrer DDX58 Anticorps)/MDA5 (Montrer IFIH1 Anticorps) signaling other than RIG-I (Montrer DDX58 Anticorps) ubiquitination via activation of NF-kappaB (Montrer NFKB1 Anticorps).
These observations highlight the importance of RIG-I (Montrer DDX58 Anticorps) signaling in anti-HIV innate immunity in macrophages, which may be beneficial for the treatment of HIV and aid in the understanding of the neuropathogenesis of HAND.
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator.
retinoic acid receptor responder (tazarotene induced) 3
, retinoic acid receptor responder protein 3
, HRAS-like suppressor 4
, RAR-responsive protein TIG3
, retinoic acid-inducible gene 1
, retinoid-inducible gene 1 protein
, tazarotene-induced gene 3 protein